Cipher Capital LP Invests $935,000 in Cigna Corp (NYSE:CI) Stock

Cipher Capital LP acquired a new stake in shares of Cigna Corp (NYSE:CI) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 4,920 shares of the health services provider’s stock, valued at approximately $935,000.

Other institutional investors also recently made changes to their positions in the company. 1 North Wealth Services LLC purchased a new position in Cigna in the 4th quarter worth approximately $25,000. Private Ocean LLC bought a new stake in shares of Cigna in the 4th quarter worth approximately $26,000. Delta Asset Management LLC TN bought a new stake in shares of Cigna in the 4th quarter worth approximately $28,000. Litman Gregory Asset Management LLC bought a new stake in shares of Cigna in the 4th quarter worth approximately $30,000. Finally, Parisi Gray Wealth Management bought a new stake in shares of Cigna in the 4th quarter worth approximately $32,000. 88.31% of the stock is currently owned by institutional investors and hedge funds.

In related news, insider Michael W. Triplett sold 9,148 shares of the stock in a transaction that occurred on Monday, February 11th. The stock was sold at an average price of $181.01, for a total transaction of $1,655,879.48. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director John Partridge sold 1,000 shares of the stock in a transaction that occurred on Thursday, February 7th. The shares were sold at an average price of $184.43, for a total value of $184,430.00. The disclosure for this sale can be found here. Over the last three months, insiders have sold 10,420 shares of company stock valued at $1,886,122. 0.80% of the stock is owned by corporate insiders.

Shares of NYSE CI traded up $3.22 during mid-day trading on Monday, reaching $163.82. The company’s stock had a trading volume of 2,614,517 shares, compared to its average volume of 2,784,611. The firm has a market cap of $62.33 billion, a price-to-earnings ratio of 11.52, a price-to-earnings-growth ratio of 0.81 and a beta of 0.71. The company has a quick ratio of 0.42, a current ratio of 0.42 and a debt-to-equity ratio of 0.96. Cigna Corp has a 52 week low of $158.00 and a 52 week high of $226.60.

Cigna (NYSE:CI) last released its quarterly earnings data on Friday, February 1st. The health services provider reported $2.46 earnings per share for the quarter, missing analysts’ consensus estimates of $2.53 by ($0.07). Cigna had a return on equity of 16.64% and a net margin of 5.42%. The business had revenue of $13.75 billion during the quarter, compared to the consensus estimate of $11.38 billion. During the same period last year, the company earned $1.94 EPS. The business’s revenue was up 29.3% on a year-over-year basis. Research analysts expect that Cigna Corp will post 16.41 EPS for the current fiscal year.

The company also recently declared a special dividend, which was paid on Wednesday, April 10th. Investors of record on Monday, March 11th were paid a dividend of $0.04 per share. The ex-dividend date of this dividend was Friday, March 8th. Cigna’s payout ratio is presently 0.28%.

A number of equities research analysts have recently weighed in on CI shares. ValuEngine lowered Cigna from a “hold” rating to a “sell” rating in a research report on Thursday, February 28th. Morgan Stanley cut their price objective on Cigna from $304.00 to $299.00 and set an “overweight” rating on the stock in a research report on Tuesday, February 5th. Goldman Sachs Group reiterated a “buy” rating on shares of Cigna in a research report on Saturday, February 2nd. Barclays reiterated a “buy” rating and issued a $220.00 price objective on shares of Cigna in a research report on Sunday, January 6th. Finally, Edward Jones started coverage on Cigna in a research report on Wednesday, January 2nd. They issued a “buy” rating on the stock. Two investment analysts have rated the stock with a sell rating, two have assigned a hold rating and thirteen have given a buy rating to the company. Cigna has an average rating of “Buy” and an average price target of $231.28.

COPYRIGHT VIOLATION WARNING: This piece of content was published by Baseball Daily News and is owned by of Baseball Daily News. If you are viewing this piece of content on another domain, it was stolen and republished in violation of U.S. & international trademark and copyright legislation. The original version of this piece of content can be accessed at

Cigna Company Profile

Cigna Corporation, a health service organization, provides insurance and related products and services in the United States and internationally. It operates through Integrated Medical, Health Services, International Markets, and Group Disability and Other segments. The Integrated Medical segment offers medical, pharmacy, dental, behavioral health and vision, health advocacy programs, and other products and services to insured and self-insured clients; Medicare Advantage, Medicare Supplement, and Medicare Part D plans to Medicare-eligible beneficiaries, as well as Medicaid plans; and health insurance coverage to individual customers on and off the public exchanges.

Read More: Marijuana Stocks Investing Considerations

Institutional Ownership by Quarter for Cigna (NYSE:CI)

Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with's FREE daily email newsletter.